A randomized double-blind placebo-controlled phase II study of the matrix metalloprotease inhibitor prinomastat in combination with temozolomide following radiation therapy in patients having newly diagnosed glioblastoma multiforme

Trial Profile

A randomized double-blind placebo-controlled phase II study of the matrix metalloprotease inhibitor prinomastat in combination with temozolomide following radiation therapy in patients having newly diagnosed glioblastoma multiforme

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2009

At a glance

  • Drugs Prinomastat; Temozolomide
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2009 Last checked against ClinicalTrials.gov record.
    • 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 11 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top